Discontinuation report TARO-TEMOZOLOMIDE
| Report ID | 123258 |
| Drug Identification Number | 02443511 |
| Brand name | TARO-TEMOZOLOMIDE |
| Common or Proper name | TEMOZOLOMIDE |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TEMOZOLOMIDE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 20 |
| ATC code | L01AX |
| ATC description | ALKYLATINGAGENTS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-07-31 |
| Remaining supply date | 2020-07-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-08-28 | French | Compare |
| v1 | 2020-08-28 | English | Compare |
Showing 1 to 2 of 2